-
HNF4A-AS1, Lipid Metabolism, and Sorafenib Resistance
2026-08-12
The 2024 Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a suppressor of sorafenib resistance in hepatocellular carcinoma by linking m6A-dependent RNA regulation to PUFA availability and ferroptosis. Its integrated database, lipidomic, mechanistic, organoid, and xenograft analyses provide a framework for studying metabolic determinants of treatment response.
-
Praeruptorin A: An Assay-First Research Framework
2026-08-11
Praeruptorin A is an angular pyranocoumarin compound with linked effects on iron handling, inflammation, barrier integrity, and tumor-cell invasion. This assay-first guide explains how to translate its DMT1–ferroptosis findings into better cardiomyopathy, ulcerative colitis, and metastasis research decisions.
-
Glabridin–Gold(I) Complex Enhances Antitumor Immunity
2026-08-11
The reference study develops complex 6d, which combines an N-heterocyclic carbene gold(I) center with glabridin to target TrxR and MAPK-linked immunosuppressive biology. In liver cancer models, the compound promoted dendritic-cell maturation, reduced suppressive immune populations, lowered PD-L1 expression, and enhanced granzyme B production, supporting a dual strategy for remodeling the tumor immune microenvironment.
-
Protein Integrity: From Lysis to Epigenetic Memory
2026-08-10
Environmental disruption can reshape developmental outcomes by compromising protein integrity before epigenetic programs are established. This thought-leadership article translates that insight into practical sample-preservation guidance, showing how an EDTA-free protease inhibitor strategy can protect mechanistic readouts without disturbing divalent-cation-dependent assays.
-
Phosbind Acrylamide: Mapping ISR Phosphorylation
2026-08-09
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis by resolving phosphorylation-dependent mobility shifts in SDS-PAGE. This guide connects the reagent to coronavirus integrated stress response research and shows how to interpret gel-based evidence alongside pathway-specific assays.
-
Melatonin–SCNF Hydrogel for Atopic Dermatitis
2026-08-08
This study developed a melatonin-loaded sacchachitin nanofiber hydrogel as a non-steroidal topical platform for atopic dermatitis. In a DNCB-induced NC/Nga mouse model, the formulation reduced disease severity, epidermal hyperplasia, mast cell infiltration, and Th2-associated biomarkers while retaining melatonin stability and hydrogel mechanical properties.
-
Fluorescein TSA Fluorescence System Kit Guide
2026-08-07
The Fluorescein TSA Fluorescence System Kit enables high-sensitivity detection of scarce proteins and nucleic acids in fixed samples. This guide connects its deposition chemistry to biomarker-selection decisions informed by miR-3180 research in hepatocellular carcinoma.
-
Z-DEVD-FMK: Caspase-3 Inhibitor Workflows for Apoptosis & Ne
2026-08-07
Z-DEVD-FMK empowers researchers to dissect apoptosis and neuroprotection by irreversibly inhibiting caspase-3 and calpain pathways. This article translates cutting-edge reference findings into detailed, actionable protocols and troubleshooting strategies for advanced cell death assays.
-
Structural Insights into Nipah Virus Polymerase Complex Asse
2026-08-06
This study elucidates the high-resolution structure of the Nipah virus (NiV) polymerase complex, revealing the detailed organization of its RNA-dependent RNA polymerase and phosphoprotein components. These findings clarify the molecular interactions essential for viral RNA synthesis, providing a structural basis for antiviral drug development targeting NiV and related zoonotic RNA viruses.
-
Catalpol’s Cardioprotective Roles: Mechanisms and Implicatio
2026-08-06
This comprehensive review synthesizes recent advances on catalpol, an iridoid glucoside, highlighting its multifaceted protective effects against cardio-cerebrovascular diseases through anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms. The evidence underscores catalpol’s therapeutic potential and the need for further translational research into natural small molecules for cardiovascular health.
-
SNS-032 (BMS-387032): Protocols and Innovations in Cancer &
2026-08-05
SNS-032 (BMS-387032) empowers researchers with precise inhibition of CDK2, CDK7, and CDK9, unlocking advanced applications in oncology and host-targeted antiviral workflows. This guide details actionable protocols, comparative advantages, and troubleshooting insights for maximizing experimental impact with this selective kinase inhibitor.
-
E4orf1 Mitigates Metabolic and Cognitive Decline in AD Mice
2026-08-05
This study demonstrates that E4orf1 expression improves glycemic control, reduces hepatic steatosis, and preserves cognitive function in a transgenic mouse model of Alzheimer’s disease. The findings highlight the potential of targeting adipose tissue metabolism as a strategy to attenuate obesity-associated cognitive decline.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Workflow Op
2026-08-04
The JC-1 Mitochondrial Membrane Potential Assay Kit empowers researchers to detect dynamic changes in mitochondrial health with high specificity, supporting both routine apoptosis assays and advanced immunomodulatory studies. Explore how evidence-based workflows, troubleshooting strategies, and lessons from recent immuno-oncology breakthroughs can maximize your data quality and experimental impact.
-
Hypoxia-Activated Photomolecular Glues Target Cyclin K in Tu
2026-08-04
This study introduces BNNC, a hypoxia-responsive photomolecular glue that selectively degrades Cyclin K and induces phototherapeutic DNA damage in cancer cells. The dual-activation mechanism enhances tumor specificity and antitumor efficacy, addressing key limitations of previous Cyclin K-targeting approaches.
-
Docosahexaenoic Acid (DHA): Optimizing Neuroprotection Resea
2026-08-03
Docosahexaenoic Acid (DHA) offers unique advantages for neuroprotection research, enabling precise modulation of oxidative stress and inflammation in both in vitro and in vivo models. This article details best-practice workflows, troubleshooting, and how APExBIO’s high-purity DHA streamlines experimental reproducibility and reliability.